1233 related articles for article (PubMed ID: 26042883)
21. Present guidelines for device implantation: clinical considerations and clinical challenges from pacing, implantable cardiac defibrillator, and cardiac resynchronization therapy.
Poole JE
Circulation; 2014 Jan; 129(3):383-94. PubMed ID: 24446408
[No Abstract] [Full Text] [Related]
22. Preferred tools and techniques for implantation of cardiac electronic devices in Europe: results of the European Heart Rhythm Association survey.
Bongiorni MG; Proclemer A; Dobreanu D; Marinskis G; Pison L; Blomstrom-Lundqvist C;
Europace; 2013 Nov; 15(11):1664-8. PubMed ID: 24170423
[TBL] [Abstract][Full Text] [Related]
23. NICE guidelines for use of implantable cardioverter defibrillators.
Saberwal B; Ahsan S
Br J Hosp Med (Lond); 2015 Jun; 76(6):316-7. PubMed ID: 26053899
[No Abstract] [Full Text] [Related]
24. Current pacemaker and defibrillator therapy.
Trappe HJ; Gummert J
Dtsch Arztebl Int; 2011 May; 108(21):372-9; quiz 380. PubMed ID: 21691561
[TBL] [Abstract][Full Text] [Related]
25. [Prevention of sudden death in heart failure patients: cardiac resynchronization therapy with or without defibrillation back-up].
Pedretti RF; Laporta A; Masnaghetti S; Raimondo R; Salerno M; Santoro F; Vaninetti R
G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):134S-136S. PubMed ID: 21416844
[TBL] [Abstract][Full Text] [Related]
26. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
Das M
Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
[TBL] [Abstract][Full Text] [Related]
27. Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillator Therapy in Advanced Heart Failure.
Choi AJ; Thomas SS; Singh JP
Heart Fail Clin; 2016 Jul; 12(3):423-36. PubMed ID: 27371518
[TBL] [Abstract][Full Text] [Related]
28. Cardiac implantable electronic device and vascular access: Strategies to overcome problems.
Kusztal M; Nowak K
J Vasc Access; 2018 Nov; 19(6):521-527. PubMed ID: 29552930
[TBL] [Abstract][Full Text] [Related]
29. Use of the Wearable Cardioverter Defibrillator as a Bridge to Implantable Cardioverter Defibrillator.
Weinstock J
Card Electrophysiol Clin; 2018 Mar; 10(1):11-16. PubMed ID: 29428131
[TBL] [Abstract][Full Text] [Related]
30. Comment on the article by Barra et al. entitled 'Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations'.
Wilson DG; Zeljko HM; Leventopoulos G; Morgan JM
Europace; 2015 Sep; 17(9):1455-6. PubMed ID: 25840287
[No Abstract] [Full Text] [Related]
31. [Electromagnetic interference : Pacemakers, cardiac resynchronization therapy devices, implantable cardioverter-defibrillator].
Nowak B; Przibille O; Napp A
Herzschrittmacherther Elektrophysiol; 2022 Sep; 33(3):297-304. PubMed ID: 35781834
[TBL] [Abstract][Full Text] [Related]
32. Implantable cardioverter defibrillators in children.
Chun TU; Collins KK; Dubin AM
Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):561-71. PubMed ID: 15225115
[TBL] [Abstract][Full Text] [Related]
33. Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association.
Raatikainen MJ; Arnar DO; Merkely B; Camm AJ; Hindricks G
Europace; 2016 Aug; 18 Suppl 3():iii1-iii79. PubMed ID: 27496955
[TBL] [Abstract][Full Text] [Related]
34. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
[TBL] [Abstract][Full Text] [Related]
35. The evolution and revolution of the implantable cardioverter defibrillator.
Indik JH
Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):461-4. PubMed ID: 15225105
[No Abstract] [Full Text] [Related]
36. Unresolved issues in implantable cardioverter-defibrillator therapy.
Mason PK; DiMarco JP
Cardiol Clin; 2008 Aug; 26(3):433-9, vii. PubMed ID: 18538189
[TBL] [Abstract][Full Text] [Related]
37. [Perioperative management of patients with cardiomyopathies: preface and comments].
Inada E
Masui; 2014 Jan; 63(1):2-4. PubMed ID: 24558925
[TBL] [Abstract][Full Text] [Related]
38. A CURE for What Ails in Cardiac Resynchronization Therapy: Defibrillator or Pacemaker Only?
Wu KC
JACC Cardiovasc Imaging; 2020 Apr; 13(4):937-939. PubMed ID: 31864988
[No Abstract] [Full Text] [Related]
39. The Gallant™ system heart rhythm management device: making a connection.
Corbisiero R; Muller D
Future Cardiol; 2022 Aug; 18(8):605-614. PubMed ID: 35748496
[TBL] [Abstract][Full Text] [Related]
40. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
